glp-1 semaglutide compound Diabetes advocacy group discourages use of compounded drugs Compounded Semaglutide (GLP-1) 6 Months

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Few studies have compared gut hormone responses between bariatric procedures

Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits

As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation